Oxford University Press

SHERPA: Yellow

People

  1. Pentsova
    Pentsova
  2. De Angelis
    De Angelis
  3. Mellinghoff
    Mellinghoff
  4. Grommes
    Grommes
  5. Kaley
    Kaley
  6. Gavrilovic
    Gavrilovic
  7. Nolan
    Nolan
  8. Boire
    Boire
  9. Lin
    Lin
  10. Young
    Young

Groups

  1. GSK Faculty (30)
  2. Human Oncology and Pathogenesis Program (29)
  3. Tow Center for Developmental Oncology (TCDO) (29)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  5. Neuroradiology Service (13)
  6. Radiology, Department of (13)
  7. Graduate Medical Education (12)
  8. Biostatistics Service (9)
  9. Epidemiology and Biostatistics (9)
  10. Summer Clinical Oncology Research Experience (SCORE) (9)
Search Within
  1. "Elena Pentsova"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (9)
Groups
  1. GSK Faculty (30)
  2. Human Oncology and Pathogenesis Program (29)
  3. Tow Center for Developmental Oncology (TCDO) (29)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  5. Neuroradiology Service (13)
  6. Radiology, Department of (13)

More Groups

People
  1. Elena Pentsova (53)
  2. Lisa De Angelis (22)
  3. Ingo Mellinghoff (17)
  4. Christian Grommes (15)
  5. Adrienne Boire (14)
  6. Marc Rosenblum (13)

More People

Years
  1. 2023 (6)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (6)
  6. 2018 (6)

More Years

Publications
  1. Neuro-Oncology (43)
  2. Neuro-Oncology Advances (4)
  3. Journal of Neuropathology and Experimental Neurology (3)
  4. Annals of Oncology (2)
  5. Neuro-Oncology Practice (1)

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolving survival in patients with leptomeningeal metastases from solid tumors
    Meeting Abstract

    Chabot, K.; Osei-Gyening, I.; Estrera, R.; Yang, J.; Pentsova, E.; Boire, A.; Wilcox, J.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies
    Meeting Abstract

    Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • IDH-mutant astrocytomas with primitive neuronal component are aggressive tumors characterized by alterations in RB1 and TP53
    Meeting Abstract

    Slocum, C.; Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Brannon, R.; Ladanyi, M.; Miller, A.; Pentsova, E.; Tabar, V.; Young, R.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Leptomeningeal disease in histone-mutant gliomas
    Journal Article

    Diaz, M.; Rana, S.; Correia, C. E. S.; Reiner, A. S.; Lin, A. L.; Miller, A. M.; Graham, M. S.; Chudsky, S.; Bale, T. A.; Rosenblum, M.; more...
    Neuro-Oncology Advances (2023)

    Fulltext@MSK | Save
  • A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics
    Journal Article

    Kumthekar, P. U.; Avram, M. J.; Lassman, A. B.; Lin, N. U.; Lee, E.; Grimm, S. A.; Schwartz, M.; Bell Burdett, K. L.; Lukas, R. V.; Dixit, K.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of IDH-mutant brainstem gliomas
    Meeting Abstract

    Kushnirsky, M.; Thakur, S.; Karajannis, M.; Bale, T.; Rosenblum, M.; Malani, R.; Gavrilovic, I. T.; Schaff, L.; Pentsova, E.; Grommes, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Correlative performance of cerebrospinal fluid (CSF) circulating tumor cells (CTC) and cell-free tumor-derived DNA (ctDNA) in leptomeningeal metastases (LM) and parenchymal brain metastases (BM)
    Meeting Abstract

    Diaz, M.; Reiner, A.; Huereca, C.; Young, R.; Arcila, M.; Rosenblum, M.; Ramanathan, L.; Bale, T.; Pentsova, E.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Neurocognitive function in patients with leptomeningeal metastasis treated with proton craniospinal irradiation
    Meeting Abstract

    Correa, D.; Koch, A.; Baser, R.; Pentsova, E.; Wolden, S.; Imber, B.; Boire, A.; Yang, J.
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Leptomeningeal disease in patients with histone-mutant gliomas
    Meeting Abstract

    Diaz, M.; Correia, C. E. S.; Lin, A.; Miller, A.; Pentsova, E.
    Neuro-Oncology (2021)

    Fulltext@MSK | Save